Elizabeth Anderson

Elizabeth McKee Anderson is currently an Independent Director at BioMarin Pharmaceutical, Inc. since 2019, Insmed, Inc. since 2018, Bavarian Nordic GmbH since 2017, Revolution Medicines, Inc. since 2015, Aro Biotherapeutics Co. since 2018, and an Independent Non-Executive Director at GSK Plc since 2022.
Ms. Anderson serves as Trustee at The Wistar Institute, Bryn Mawr Hospital Foundation, The Haverford School, and as Trustee & Principal at PureSight Advisory LLC.
Former roles include Independent Director at Bavarian Nordic A from 2017 to 2022, Independent Non-Executive Director at Huntsworth Ltd. from 2018 to 2019, Director at Context Therapeutics LLC from 2018 to 2021, Vice President & General Manager-Wyeth Lederle Vaccines at Johnson & Johnson from 1997 to 2009, Vice President-Infectious Disease & Vaccines at Janssen Pharmaceuticals, Inc. from 2003 to 2014, Vice President-Plasma Operations at The American National Red Cross from 1989 to 1993, Senior Vice President & General Manager at Rhone-Poulenc Rorer Pharmaceuticals, Inc. from 1993 to 1997, VP-Business Operations & GM-North America at Armour Pharmaceutical Co. from 1993 to 1997, Senior Vice President & GM-North America at Centeon LLC from 1993 to 1997, Vice President & General Manager at Wyeth Lederle Vaccines SA from 1997 to 2002, and Director at Centocor, Inc. and Crucell Vaccines, Inc. Education includes an undergraduate degree from Rutgers State University of New Jersey in 1979 and an MBA from Sellinger School of Business & Management.